Burlington, MA, United States of America

Oscar Miguel Moradei

This inventor holds 32 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Arginine Methyltransferase Inhibitors. Top assignees: Epizyme, Inc., Methylgene, Inc., Merck Canada Inc.. Active years: 2009-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oscar Miguel Moradei. Retrieved from https://idiyas.com/inventor/oscar-miguel-moradei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 10)

% Patents Active = 78.1

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 6.0

ph-index = 15

Forward Citations = 580(Granted Patents)

Location History:

Kirkland, CA (2009 - 2017)
Burlington, MA (US) (2015 - 2023)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...

Areas of Expertise:

CARM1 Inhibitors

PRMT1 Inhibitors

HIV Protease Inhibitors

Arginine Methyltransferase

Histone Deacetylase

Pyrazole Derivatives

Sulfonamides

Spiro Compounds

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11834455 - Carm1 inhibitors and uses thereof (2023-12-05),

2. 10633389 - CARM1 inhibitors and uses thereof (2020-04-28),

3. 10118931 - CARM1 inhibitors and uses thereof (2018-11-06),

4. 10039748 - PRMT1 inhibitors and uses thereof (2018-08-07),

5. 9994587 - HIV protease inhibitors (2018-06-12),

6. 9856267 - CARM1 inhibitors and uses thereof (2018-01-02),

7. 9834526 - HIV protease inhibitors (2017-12-05),

8. 9776972 - Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof (2017-10-03),

9. 9738651 - CARM1 inhibitors and uses thereof (2017-08-22),

10. 9737545 - HIV protease inhibitors (2017-08-22),

11. 9732041 - Arginine methyltransferase inhibitors and uses thereof (2017-08-15),

12. 9718816 - 1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereof (2017-08-01),

13. 9630961 - Arginine methyltransferase inhibitors and uses thereof (2017-04-25),

14. 9447079 - PRMT1 inhibitors and uses thereof (2016-09-20),

15. 9440950 - Arginine methyltransferase inhibitors and uses thereof (2016-09-13),

Title: Unveiling the Innovative Mind of Inventor Oscar Miguel Moradei

Introduction:

Meet the prolific inventor Oscar Miguel Moradei, whose groundbreaking work has left an indelible mark on the world of pharmaceuticals and biotechnology. Hailing from Burlington, MA (US), Moradei is a visionary with a total of 32 patents under his name, showcasing his exceptional talent and dedication to innovation.

Latest Patents:

Moradei's recent patents include "CARM1 Inhibitors and Uses Thereof," where he introduces compounds designed to inhibit CARM1 activity. These compounds hold immense potential for treating CARM1-mediated disorders, offering hope for patients in need of effective therapeutic interventions.

Career Highlights:

Throughout his career, Moradei has made significant contributions to companies such as Epizyme, Inc., and Methylgene, Inc., where his expertise and innovative spirit have propelled research and development in the field of biopharmaceuticals. His relentless pursuit of excellence has led to the creation of novel compounds that have the power to revolutionize the treatment of various diseases.

Collaborations:

Moradei's collaborations with esteemed professionals such as Gideon Shapiro and Richard Chesworth have been instrumental in driving forward pioneering research projects. By fostering a culture of teamwork and knowledge-sharing, Moradei has enriched the collaborative landscape within the pharmaceutical industry, paving the way for transformative discoveries.

Conclusion:

In conclusion, Oscar Miguel Moradei stands as a trailblazing inventor whose passion for innovation and commitment to scientific advancement have reshaped the landscape of biopharmaceuticals. His remarkable achievements underscore the importance of ingenuity and perseverance in driving progress and improving the lives of countless individuals worldwide.

Profile summary based on public USPTO records.